Boult Wade Tennant
News » The Biotechnology and Life Sciences group discuss CRISPR with Biotech and Money

Patent Attorney Edward Ronan and Trainee Patent Attorney Nadia Tyler-Rubinstein cover the latest developments in the case against CRISPR with Biotech and Money magazine. The recent decision on this case highlights the importance of robust IP practices in the early stages of protecting your technology, even more so where IP requirements may differ between countries.

Read their coverage here.

Sector experience
Consumer goods and retail
Food and beverage
Artificial intelligence and machine learning
Trade marks
Chemicals
Materials
Industrial manufacturing and processing
Electronics and electrical devices
Communications and networks 
Energy and green technologies
Automotive
Aerospace
Pharmaceuticals
Biotechnology
Medical devices and diagnostics 
Computing and software 
Relevant sectors
Aerospace
Artificial intelligence and machine learning
Automotive
Biotechnology
Chemicals
Communications and networks 
Computing and software 
Consumer goods and retail
Electronics and electrical devices
Energy and green technologies
Food and beverage
Industrial manufacturing and processing
Materials
Medical devices and diagnostics 
Pharmaceuticals
Trade marks
Relevant sectors